Stakeholders Grapple With Curbing Bias In AI-Based Medical Devices

By Kelly Lienhard / June 23, 2022 at 10:17 AM
FDA and medical device developers are grappling with how to eliminate bias in artificial intelligence and machine learning technologies, but there’s a lack of consensus on how to combat bias and ensure AI-enabled devices can be used across populations. Some stakeholders say FDA should use its current authorities to implement labeling requirements for AI devices and incorporate subpopulation analysis into its decision-making process, while industry representatives say the agency should focus on providing incentives, rather than creating new requirements, for...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.